Vitara Biomedical developed a therapeutic platform to support premature infants.
Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 13, 2022 | Series B | $75M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
The Children's Hospital of Philadelphia | — | Series B |